The report, presented by the Alliance for Patient Access (AfPA) and titled “Biosimilars: Can They Break Through?” will include discussion on the policy issues surrounding biosimilars in the United States. Topics will include:
- Given pending FDA regulations, what are the obstacles in getting biosimilars to market?
- What are the concerns surrounding the labeling or prescriber information, and why is the issue of naming so hotly contested?
People
Related Insights
June 2, 2025
Labor & Employment Law Perspectives
Update on DHS Efforts to Terminate TPS and Parole Status for Various Immigrant Groups
The U.S. Department of Homeland Security (DHS) has been actively working to terminate Temporary Protected Status (TPS) and Parole status…
June 2, 2025
Labor & Employment Law Perspectives
Circuit Split Deepens on “Harm” as a Failure to Accommodate Element
The split among federal circuit courts of appeal as to whether a disabled worker must show harm in bringing a failure to accommodate…
May 30, 2025
Foley Career Perspectives
Foley Mental Health Month Program: Enhancing Performance Through High-Quality Connections
Foley & Lardner endeavors to create a high-performance culture that also prioritizes well-being — a culture where every member of the…